Commission’s D’Acunto Tells EU Industry To Talk Less About Bottlenecks
Executive Summary
The medical technology industry has lobbied the European Commission hard because it believes the time it has to comply with the new Medical Device and IVD Regulations is much too short and threatens product availability. But the commission has hit back at these claims.
You may also be interested in...
MedTech Forum 2019: In The Medtech Glasshouse, Industry Need Not Fear Stones
Medtech’s contribution to health care improvements in Europe over the past 30 years has been a phenomenal journey of success – in patient terms as well as in commercial terms, says MedTech Europe chair Rob ten Hoedt. Local creativity has been able to mine a seam of product innovation that is unmatched anywhere in the world, but the sector is facing massive change and must find ways to cope.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.